Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (2018 - 2026)
Arcturus Therapeutics Holdings' Cash & Equivalents came in at $191.48 million for Q2 2026, down 2.5% from $196.47 million a year earlier and down 9.4% from the prior quarter.
Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Arcturus Therapeutics Holdings' Cash & Equivalents was $230.91 million, down 21.4% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $293.91 million in FY2024 (+0.7%), $292.01 million in FY2023 (-25.5%), $391.88 million in FY2022 (+5.8%) and $370.49 million in FY2021 (-20.0%).
- The five-year range for quarterly Cash & Equivalents is $180.36 million (Q3 2025) to $413.88 million (Q3 2021).
- Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 15.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 34.8%), and the weakest in Q3 2022 (a decline of 42.6%).
- Business Quant data shows ARCT's Cash & Equivalents at $211.38 million (Q1 2026), $230.91 million (Q4 2025) and $180.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Arcturus Therapeutics Holdings | 267.25 Mn | -551.34 Mn | - | 184.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 184.82 Mn |
| Jun 30, 2026 | 191.48 Mn |
| Mar 31, 2026 | 211.38 Mn |
| Dec 31, 2025 | 230.91 Mn |
| Sep 30, 2025 | 180.36 Mn |
| Jun 30, 2025 | 196.47 Mn |
| Mar 31, 2025 | 216.95 Mn |
| Dec 31, 2024 | 293.91 Mn |
| Sep 30, 2024 | 237.18 Mn |
| Jun 30, 2024 | 260.33 Mn |
| Mar 31, 2024 | 288.40 Mn |
| Dec 31, 2023 | 292.01 Mn |
| Sep 30, 2023 | 311.92 Mn |
| Jun 30, 2023 | 323.47 Mn |
| Mar 31, 2023 | 327.94 Mn |
| Dec 31, 2022 | 391.88 Mn |
| Sep 30, 2022 | 237.68 Mn |
| Jun 30, 2022 | 283.49 Mn |
| Mar 31, 2022 | 319.68 Mn |
| Dec 31, 2021 | 370.49 Mn |
Arcturus Therapeutics Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();